Baraclude directly suffering from 53.55% price cuts
A hepatitis B treatment which had kept the No. 1 position in the prescription market for several years, ‘Baraclude’ is now experiencing sharp decreases in prescription in a year of its patent expiration.
It is true insurance coverage extension of its competing drug ‘Viread’ was one of the reason...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
